As the US military moves forward with plans to routinely measure testosterone in male servicemembers aged ≥ 30 years, a cross ...
In patients with aortic stenosis accompanied by at least one risk factor, transcatheter valve replacement produces a large ...
Even in patients most likely to benefit, a 25-year follow-up in the landmark COURAGE trial has not shown percutaneous ...
A phase 2 trial compares dual-targeted CAR T-cell therapy with R-GemOx as second-line treatment for patients with relapsed or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results